Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 585.80
-10.75 (-1.80%)
At close: Mar 27, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 11.95 billion as of March 27, 2026. Its market cap has increased by 6.58% in one year.
Market Cap
11.95B
Enterprise Value
9.63B
Revenue
6.52B
Ranking
n/a
PE Ratio
13.60
Stock Price
585.80
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 11.95B, an increase of 8,502.10%. That is a compound annual growth rate of 23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 11.95B | 23.46% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hikal | 19.97B |
| Kwality Pharmaceuticals | 15.19B |
| Amrutanjan Health Care | 14.94B |
| Shukra Pharmaceuticals | 14.91B |
| Venus Remedies | 11.79B |
| TTK Healthcare | 11.05B |
| Syncom Formulations (India) | 10.87B |
| Fermenta Biotech | 10.57B |